SNTI
Senti Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$30.74M
P/E Ratio
—
EPS
$-1.46
Beta
2.10
52W High
$3.88
52W Low
$0.77
50-Day MA
$0.95
200-Day MA
$1.32
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Senti Biosciences Inc
Senti Biosciences Inc (SNTI) is a cutting-edge biotechnology firm focused on advancing synthetic biology through its proprietary GeneCircuit platform, which enables the creation of programmable cell and gene therapies. The company is dedicated to addressing various diseases, including cancer and genetic disorders, with a strong emphasis on personalized medicine. Senti's promising development pipeline, combined with strategic partnerships, positions it well to lead the innovation of engineered cell therapies and provide transformative solutions to meet significant unmet medical needs within the biopharmaceutical landscape.
Fundamentals
| Revenue (TTM) | 38,000 |
| Gross Profit (TTM) | $-37.55M |
| EBITDA | $-51.42M |
| Operating Margin | -71362.00% |
| Return on Equity | -218.10% |
| Return on Assets | -48.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.18 |
| Price-to-Book | 11.98 |
| Price-to-Sales (TTM) | 808.86 |
| EV/Revenue | 1077.44 |
| EV/EBITDA | -0.28 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $31.14M |
| Float | $14.58M |
| % Insiders | 47.91% |
| % Institutions | 18.50% |
Historical Volatility
HV 10-Day
93.88%
HV 20-Day
91.94%
HV 30-Day
97.24%
HV 60-Day
81.10%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($11.25 target)
1
Strong Buy3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026